| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1238 | 2020 |
| Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci A Cortes, J Hadler, JP Pointon, PC Robinson, T Karaderi, P Leo, ... Nature genetics 45 (7), 730-738, 2013 | 805 | 2013 |
| Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci D Ellinghaus, L Jostins, SL Spain, A Cortes, J Bethune, B Han, YR Park, ... Nature genetics 48 (5), 510, 2016 | 795 | 2016 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 694 | 2021 |
| Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis ME Costello, F Ciccia, D Willner, N Warrington, PC Robinson, B Gardiner, ... Arthritis & Rheumatology 67 (3), 686-691, 2015 | 481 | 2015 |
| Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 A Cortes, SL Pulit, PJ Leo, JJ Pointon, PC Robinson, MH Weisman, ... Nature communications 6 (1), 1-8, 2015 | 294 | 2015 |
| Rheumatic disease and COVID-19: initial data from the COVID-19 global rheumatology alliance provider registries MA Gianfrancesco, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... The Lancet Rheumatology 2 (5), e250-e253, 2020 | 257 | 2020 |
| Ankylosing spondylitis S Van Der Linden, M Brown, T Kenna, W Maksymowych, P Robinson Kelley and Firestein's textbook of rheumatology (Tenth Edition), 1256-1279, 2017 | 256 | 2017 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 249 | 2021 |
| Genetics of ankylosing spondylitis PC Robinson, MA Brown Molecular immunology 57 (1), 2-11, 2014 | 183 | 2014 |
| COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations R Grainger, AHJ Kim, R Conway, J Yazdany, PC Robinson Nature Reviews Rheumatology 18 (4), 191-204, 2022 | 172 | 2022 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 167 | 2021 |
| COVID-19 therapeutics: Challenges and directions for the future PC Robinson, DFL Liew, HL Tanner, JR Grainger, RA Dwek, RB Reisler, ... Proceedings of the National Academy of Sciences 119 (15), e2119893119, 2022 | 161 | 2022 |
| Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials S Stewart, KCK Yang, K Atkins, N Dalbeth, PC Robinson Arthritis Research & Therapy 22 (1), 1-15, 2020 | 157 | 2020 |
| SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 153 | 2022 |
| Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment PC Robinson, D Richards, HL Tanner, M Feldmann The Lancet Rheumatology 2 (11), e653-e655, 2020 | 148 | 2020 |
| Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis PC Robinson, TAM Claushuis, A Cortes, TM Martin, DM Evans, P Leo, ... Arthritis & Rheumatology 67 (1), 140-151, 2015 | 140 | 2015 |
| The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19 PC Robinson, DFL Liew, JW Liew, C Monaco, D Richards, S Shivakumar, ... Med 1 (1), 90-102, 2020 | 134 | 2020 |
| Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 127 | 2021 |
| Axial spondyloarthritis: concept, construct, classification and implications for therapy PC Robinson, S van der Linden, MA Khan, WJ Taylor Nature Reviews Rheumatology 17 (2), 109-118, 2021 | 127 | 2021 |
Jinoos YazdanyUCSFPatvirtintas el. paštas ucsf.edu
